Personalized Follow-Up of QOL in Longitudinal Studies: The example of promising experimental treatment of recurrent Glioblastoma with avelumab and axitinib
Theuns, P. (Speaker), Anne Rogiers (Contributor), De Cremer, J. (Contributor), Laïla Ben Salama (Contributor), Jan Bernheim (Contributor), B. Neyns (Contributor)
Activity: Talk or presentation › Talk or presentation at a conference